Yuki Oba

448 total citations
60 papers, 144 citations indexed

About

Yuki Oba is a scholar working on Nephrology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuki Oba has authored 60 papers receiving a total of 144 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Nephrology, 21 papers in Rheumatology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuki Oba's work include Renal Diseases and Glomerulopathies (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Genetic and Kidney Cyst Diseases (9 papers). Yuki Oba is often cited by papers focused on Renal Diseases and Glomerulopathies (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers) and Genetic and Kidney Cyst Diseases (9 papers). Yuki Oba collaborates with scholars based in Japan and Singapore. Yuki Oba's co-authors include Naoki Sawa, Hiroki Mizuno, Yoshifumi Ubara, Masayuki Yamanouchi, Akinari Sekine, Tatsuya Suwabe, Eiko Hasegawa, Keiichi Kinowaki, Junichi Hoshino and Noriaki Ohuchi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of the Rheumatic Diseases.

In The Last Decade

Yuki Oba

45 papers receiving 144 citations

Peers

Countries citing papers authored by Yuki Oba

Since Specialization

Citations

This map shows the geographic impact of Yuki Oba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Oba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Oba more than expected).

Fields of papers citing papers by Yuki Oba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Oba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Oba. The network helps show where Yuki Oba may publish in the future.

Co-authorship network of co-authors of Yuki Oba

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Oba. A scholar is included among the top collaborators of Yuki Oba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Oba. Yuki Oba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sarcoidosis Induced by Metal Particles From a Left Elbow Prosthesis 2025 ·Kidney Medicine ·(unknown), (unknown), (unknown), (unknown), Yuki Oba, Hiroki Mizuno, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, (unknown), (unknown), Keiichi Kinowaki, Kenichi Ohashi, (unknown), Kei Takahashi, Yoshifumi Ubara	0
2	A patient with certolizumab pegol-induced palmoplantar pustulosis or pustulotic arthro-osteitis: a case report 2025 ·Modern Rheumatology Case Reports ·(unknown), (unknown), Yuki Oba, Shigekazu Kurihara, Akinari Sekine, (unknown), Tatsuya Suwabe, Eiko Hasegawa, Akiko Kishi, Nobukazu Hayashi, (unknown), Yutaka Takazawa, Takehiko Wada, Yoshifumi Ubara	0
3	Finerenone and Estimated GFR Slope in Type 2 Diabetes and CKD 2025 ·Kidney International Reports ·Masayuki Yamanouchi, Yuki Oba, (unknown), (unknown), Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Akinari Sekine, Tatsuya Suwabe, (unknown), (unknown), Kengo Furuichi, Takashi Wada, Yoshifumi Ubara	1
4	Efficacy of SGLT2 inhibitors in IgA nephropathy associated with alcoholic liver cirrhosis accompanied by nephrotic syndrome: a case report 2024 ·SHILAP Revista de lepidopterología ·Yusuke Yoshimura, (unknown), Hiroki Mizuno, (unknown), Keiichi Kinowaki, Hisashi Sugimoto, (unknown), (unknown), (unknown), Shigekazu Kurihara, Yuki Oba, Masayuki Yamanouchi, Tatsuya Suwabe, Kenichi Ohashi, Yoshifumi Ubara, Naoki Sawa	1
5	Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver Disease 2024 ·Internal Medicine ·(unknown), Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Masayuki Yamanouchi, Hiroki Mizuno, (unknown), Eiko Hasegawa, Yuki Oba, (unknown), Keiichi Kinowaki, Kenichi Ohashi, Naoki Sawa, Yoshifumi Ubara	1
6	INVS Mutation-Related NPHP2 Nephronophthisis With Glomerulocystic Disease: A Case Report 2024 ·Kidney Medicine ·(unknown), Akinari Sekine, Yuki Oba, Masayuki Yamanouchi, Tatsuya Suwabe, (unknown), Keiichi Kinowaki, Kenichi Ohashi, Yutaka Yamaguchi, Takuya Fujimaru, Takayasu Mori, (unknown), (unknown), Takehiko Wada, Naoki Sawa, Yoshifumi Ubara	0
7	A case of renal limited myeloperoxidase anti-neutrophil cytoplasmic antibody-positive vasculitis treated with maintenance avacopan monotherapy 2024 ·CEN Case Reports ·Yoshifumi Ubara, Yuki Oba, Shigekazu Kurihara, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, (unknown), Kenichi Ohashi, Takehiko Wada, Naoki Sawa	1
8	Renal cell carcinoma preceded by a rheumatoid‑like paraneoplastic syndrome: A case report 2024 ·Oncology Letters ·Yusuke Yoshimura, Tatsuya Suwabe, (unknown), Takayoshi Yokoyama, (unknown), Keiichi Kinowaki, Ikuma Kato, Yoji Nagashima, Asami Nishikori, Yasuharu Sato, Shigekazu Kurihara, Yuki Oba, Hiroki Mizuno, Akinari Sekine, Masayuki Yamanouchi, (unknown), Yasuo Ishíi, Yuki Nakamura, Yoshifumi Ubara, Naoki Sawa	1
9	Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease 2024 ·Annals of the Rheumatic Diseases ·Yusuke Yoshimura, Masayuki Yamanouchi, Hiroki Mizuno, (unknown), Ryo Koizumi, Shigekazu Kurihara, Yuki Oba, Tatsuya Suwabe, (unknown), (unknown), Hisashi Sugimoto, (unknown), Akinari Sekine, Eiko Hasegawa, Yoshifumi Ubara, Naoki Sawa	3
10	Is Podocytopathy Associated with Gross Hematuria after COVID-19 Vaccination in Patients with Immunoglobulin A Nephropathy? 2024 ·Internal Medicine ·(unknown), (unknown), Yuki Oba, (unknown), Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Hiroki Mizuno, Tatsuya Suwabe, (unknown), Keiichi Kinowaki, Kenichi Ohashi, (unknown), Yutaka Yamaguchi, Noriko Uesugi, Yoshifumi Ubara	0
11	A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment 2024 ·CEN Case Reports ·Yoshifumi Ubara, (unknown), Eiko Hasegawa, Akinari Sekine, (unknown), (unknown), Hiroki Mizuno, Yuki Oba, Masayuki Yamanouchi, Tatsuya Suwabe, (unknown), Keiichi Kinowaki, Kenichi Ohashi, Yutaka Yamaguchi, Naoki Sawa, Takehiko Wada	1
12	Acute Eosinophilic Granulomatous Tubulointerstitial Nephritis in a Patient Receiving Combination Treatment with Three Drugs 2024 ·Internal Medicine ·(unknown), Eiko Hasegawa, Yuki Oba, Hiroki Mizuno, Shigekazu Kurihara, (unknown), Akinari Sekine, (unknown), Masayuki Yamanouchi, Tatsuya Suwabe, (unknown), Keiichi Kinowaki, Kenichi Ohashi, Yutaka Yamaguchi, Takehiko Wada, Naoki Sawa, Yoshifumi Ubara	0
13	Glomerular Microangiopathy-like Nephropathy Caused by Hyperthyroidism 2023 ·Internal Medicine ·(unknown), Naoki Sawa, Shigekazu Kurihara, (unknown), Yuki Oba, Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Takehiko Wada, (unknown), Keiichi Kinowaki, Kenichi Ohashi, Yoshiki Tsuchiya, Yoshifumi Ubara	0
14	A Half-Century Dialysis Survivor: Clinical and Autopsy Findings 2023 ·Kidney Medicine ·(unknown), Tatsuya Suwabe, Yuki Oba, (unknown), Hiroki Mizuno, Akinari Sekine, Eiko Hasegawa, Masayuki Yamanouchi, Junichi Hoshino, (unknown), (unknown), (unknown), Takeshi Fuji, Kenichi Ohashi, Naoki Sawa, Yoshifumi Ubara	3
15	Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation 2023 ·SHILAP Revista de lepidopterología ·Tatsuya Suwabe, Yoshifumi Ubara, Yuki Oba, Hiroki Mizuno, (unknown), Masayuki Yamanouchi, Akinari Sekine, (unknown), Eiko Hasegawa, Junichi Hoshino, Naoki Sawa	1
16	Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination 2023 ·Internal Medicine ·(unknown), Naoki Sawa, Hiroki Mizuno, Yuki Oba, (unknown), Akinari Sekine, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, (unknown), (unknown), Keiichi Kinowaki, Kenji Notohara, Yoshifumi Ubara	3
17	Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease 2023 ·Journal of Nephrology ·Tatsuya Suwabe, Yoshifumi Ubara, Yuki Oba, Hiroki Mizuno, (unknown), Masayuki Yamanouchi, Akinari Sekine, (unknown), Eiko Hasegawa, Junichi Hoshino, Naoki Sawa	3
18	Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease 2023 ·Kidney International Reports ·Masayuki Yamanouchi, Naoki Sawa, Tadashi Toyama, Miho Shimizu, Megumi Oshima, Yusuke Yoshimura, Hisashi Sugimoto, Shigekazu Kurihara, Yuki Oba, (unknown), Hiroki Mizuno, Akinari Sekine, Tatsuya Suwabe, Junichi Hoshino, Yoshifumi Ubara, Shigeko Hara, Kengo Furuichi, Takashi Wada	4
19	Successful Case of Deceased Donor Liver Transplant for Polycystic Liver Disease 2022 ·Transplantation Proceedings ·Hisashi Sugimoto, Yôichi Ôshima, Yuki Oba, (unknown), Akinari Sekine, Hiroki Mizuno, Masayuki Yamanouchi, Eiko Hasegawa, Tatsuya Suwabe, Po–Sung Chu, Yasushi Hasegawa, Hideaki Obara, Naoki Sawa, Yoshifumi Ubara	3
20	Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B With Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy 2020 ·Kidney Medicine ·Yuki Oba, Naoki Sawa, Hiroki Mizuno, Junichi Hoshino, Keiichi Kinowaki, Kenichi Ohashi, Naoya Morisada, Kazumoto Iijima, Yutaka Yamaguchi, Yoshifumi Ubara	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact